1. Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab. Issue 7 (20th March 2020) Authors: Fabbri, Alice; O'Keeffe, Mary; Moynihan, Ray; Møllebæk, Mathias; Mohammad, Annim; Bhasale, Alice; Puil, Lorri; Mintzes, Barbara Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 7(2020) Page Start: 1416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Regulating patient access to therapeutics in Denmark: a rhetorical analysis of welfare imaginaries in public controversy. Issue 2 (21st September 2020) Authors: Møllebæk, Mathias Journal: Journal of law and the biosciences Issue: Volume 8:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warnings. Issue 2 (16th August 2021) Authors: Bhasale, Alice L.; Sarpatwari, Ameet; Lipworth, Wendy; Møllebæk, Mathias; McEwin, Eliza J.; Gautam, Nileesa; Santiago Ortiz, Adrian; Mintzes, Barbara J. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 2(2022) Page Start: 713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Why do general practitioners disregard direct to healthcare professional communication? A user‐oriented evaluation to improve drug safety communication. Issue 3 (28th October 2020) Authors: Møllebæk, Mathias; Kaae, Susanne Journal: Basic & clinical pharmacology & toxicology Issue: Volume 128:Issue 3(2021) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗